Seal Rock Therapeutics
Seal Rock Therapeutics is a developer of small molecule inhibitors used to treat inflammatory and fibrotic conditions.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Seal Rock Therapeutics Information
Geographic Data
Address: 500 Yale Ave N
City: Seattle
State: WA
Zip: 98109
Country: US
Financial Info
Stage:
seed
Raised Last:
$0
Raised Total:$3M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Seal Rock Therapeutics is a developer of small-molecule inhibitors of ASK1 (Apoptosis signal-regulating kinase 1), a protein that mediates apoptosis, inflammation, and fibrosis. Seal Rock is currently focusing its efforts on hepatic indications including NASH (non-alcoholic steatohepatitis), a condition resulting from fatty liver disease, characterized by hepatic inflammation and cellular damage that lead to liver fibrosis. Additional opportunities with ASK1 inhibitors include cardiac, immunological, and neurodegenerative indications.
Contact Phone:
+12064015086
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2022 | Debt | $2.5M | 1/2018 | Seed Round | 1 | - |
Life Science Angels Life Science Angels |
1/2017 | Seed Round | 1 | - |
Life Science Angels Life Science Angels |
1/2018 | Seed Round | 1 | - |
Life Science Angels Life Science Angels |
1/2017 | Seed Round | 1 | - |
Life Science Angels Life Science Angels |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
